Summary of Key Points from Conference Call Records Industry Overview - The data pertains to the footwear and apparel industry, specifically focusing on sales performance on the Douyin platform for January and February. Key Insights and Arguments - **Overall Sales Growth**: Most footwear and apparel brands reported positive sales growth for January and February, as indicated by the sales index from the Douyin platform [1][1]. - **Outdoor Brands Performance**: - Strong growth observed in outdoor brands, with notable performances: - Decathlon: +75% - Camel: +44% - Mobi Garden: +350% - Salomon: +117% - Wilson: +318% - Descente: +10% - KAILAS: +71% - LeFay: +96% - BERSHKA: +109% - KOLON: +79% - Arc'teryx: -13% - Pathfinder: +36% [1][1]. - **Sports Brands Performance**: - Overall positive performance in the sports brand sector: - Anta: +26% - Fila: +34% - Li Ning: +42.2% - Xtep: +39% - Adidas: +48% - Nike: +3% - Lululemon: +90% - Saucony: -17% - 361 Degrees: +16% [2][2]. - **Home Textile Sector**: - Mixed results in the home textile industry: - Luolai: +51% - Mercury Home Textile: +6% - Fuanna: +224% - Atour Planet: +31% [2][2]. - **Men's Apparel Sector**: - Strong performance noted in the men's clothing sector: - Hazzys: +55% - Baoxini: +104% - Biyinlefen: +279% - Hailan Home: +54% - Jiumuwang: +49% - Lilang: +73% [3][3]. - **Casual Wear and Children's Apparel**: - Casual wear showed weaker performance: - Uniqlo: +0.4% - Semir: +1.8% - Taiping Bird: +10.5% - Le Temps: -42% - Balabala: +30% [4][4]. Additional Important Information - The sales data is derived from the sales index, which is based on transaction-related data from the Douyin platform, and may not accurately reflect actual sales figures, indicating potential discrepancies [1][1].

Core Viewpoint - The article highlights the significant role of Jiuwang in supporting China's sports initiatives, particularly during the Milan Winter Olympics, showcasing its commitment to high-quality sportswear and engaging marketing strategies to connect with consumers [1][3][21]. Group 1: Sponsorship and Brand Presence - Jiuwang serves as the official sponsor of the Chinese Olympic Committee, providing high-quality apparel for over a hundred officials participating in the Winter Olympics [1][21]. - The brand has a history of collaborating with the Chinese Olympic Committee, having designed ceremonial outfits for various events since 2018, including the Jakarta Asian Games and the Tokyo Olympics [3][13]. Group 2: Marketing and Consumer Engagement - Jiuwang has partnered with Migu Video to create an immersive viewing experience for the Winter Olympics, focusing on key events where the Chinese team is expected to excel [5][15]. - The company has launched a nationwide prize-winning guessing game related to the Winter Olympics, encouraging consumer participation and enhancing brand engagement through multiple channels [8][18]. Group 3: Brand Philosophy and Vision - Jiuwang emphasizes a comprehensive marketing approach that integrates professional support for athletes with consumer engagement, reflecting the spirit of sportsmanship [11][21]. - The brand aims to embody the craftsmanship and dedication of Chinese manufacturing, aligning itself with the aspirations of the Chinese athletes and the broader national pride during the Winter Olympics [11][21].

Group 1 - The core viewpoint of the article is that Jiuwu Wang has announced an expected increase in net profit for the year 2025, projecting a range of 27 million to 32.4 million yuan, which represents a year-on-year increase of 9.379 million to 14.779 million yuan, translating to a growth rate of 54% to 84% [1] Group 2 - The company anticipates achieving a net profit attributable to shareholders of the listed company in 2025 [1] - The projected profit increase indicates a strong financial performance compared to the previous year [1] - The announcement reflects the company's positive outlook and growth potential in the upcoming years [1]

Core Viewpoint - Jiumuwang forecasts a net profit attributable to shareholders of 270 million to 324 million yuan for the year 2025, representing an increase of 93.79 million to 148 million yuan compared to the previous year, with a year-on-year growth of 54% to 84% [1] Financial Performance - The expected net profit for 2025 is projected to be between 270 million and 324 million yuan [1] - This represents an increase of 93.79 million to 148 million yuan compared to the previous year's performance [1] - The anticipated growth rate is between 54% and 84% year-on-year [1]

Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]

Group 1 - The company, Jiumuwang (601566.SH), expects to achieve a net profit attributable to shareholders of the listed company between 270 million yuan and 324 million yuan for the year 2025, representing a year-on-year growth of 54% to 84% [1]

Group 1 - The company, Jomoo (601566.SH), expects to achieve a net profit attributable to shareholders of between 270 million to 324 million yuan for the year 2025, representing a year-on-year growth of 54% to 84% [1]

Group 1 - The company Jiumuwang announced an earnings forecast on January 29, expecting a net profit attributable to shareholders of 270 million to 324 million yuan for the year 2025, representing an increase of 93.79 million to 148 million yuan compared to the same period last year, with a year-on-year growth of 54% to 84% [1] - The primary reason for the performance change is the impact of non-operating gains and losses, with the fair value change of financial assets held by the company expected to be between 80 million to 90 million yuan, compared to a loss of 58.55 million yuan in the same period last year, indicating an increase of approximately 140 million yuan in fair value change gains [1]

Core Viewpoint - Jiumuwang (601566.SH) expects a significant increase in net profit for the year 2025, indicating strong growth potential despite a decline in net profit excluding non-recurring items [1] Financial Performance - The company anticipates a net profit attributable to shareholders of 270 million to 324 million yuan for 2025, representing an increase of 93.79 million to 147.79 million yuan compared to the previous year, which translates to a year-on-year growth of 54% to 84% [1] - The expected net profit excluding non-recurring items is projected to be 135 million to 162 million yuan, reflecting a decrease of 39.06 million to 66.06 million yuan from the previous year, resulting in a year-on-year decline of 19% to 33% [1]

证券代码：601566 证券简称：九牧王 公告编号：临 2026-002 九牧王股份有限公司 2025 年年度业绩预增的公告 （三）本次业绩预告是公司财务部门初步测算结果，会计师事务所对本次业 绩预告未进行审计。 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日。 （二）业绩预告情况 1、经公司财务部门初步测算，预计 2025 年年度实现归属于上市公司股东的 净利润 27,000 万元~32,400 万元，较上年同期增加 9,379 万元~14,779 万元，同比 增长 54%~84%。 2、预计 2025 年年度实现归属于上市公司股东的扣除非经常性损益的净利润 13,500 万元~16,200 万元，较上年同期减少 3,906 万元~6,606 万元，同比下降 19%~33%。 1 / 2 本次业绩预告适用情形：实现盈利，且净利润较上年同期增长 50%以上。 经财务部门初步测算，预计九牧王股份有限公司 ...